Kimberly-Clark Buying Tylenol Maker Kenvue
Digest more
I would like to receive updates and special offers from Dow Jones and affiliates. I can unsubscribe at any time.
Kimberly-Clark is buying Tylenol maker Kenvue in an approximately $48.7 billion cash-and-stock deal, creating a massive ...
Little more than a month after making specious claims that there’s a link between Tylenol use and autism, Health and Human ...
Potentially huge legal issues are hovering over Kenvue. But Kimberly-Clark, which agreed to buy it for $40 billion, appears ...
Many expectant moms are unaware of the dangers of cannabis use.
Not long after President Trump made his statement, Kenvue and Johnson & Johnson got into another complicated legal mess when ...
Kimberly-Clark Chairman and CEO Mike Hsu joins 'Mad Money' host Jim Cramer to talk the recent acquisition of Kenvue, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback